<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Centre for Infection &amp; Immunity</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CACE3C60-286D-41DE-B6C8-11ECB4934262"><gtr:id>CACE3C60-286D-41DE-B6C8-11ECB4934262</gtr:id><gtr:firstName>Adrien</gtr:firstName><gtr:surname>Kissenpfennig</gtr:surname><gtr:orcidId>0000-0002-9633-3111</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/51E3860D-5758-4DC7-A545-68AD267FA83F"><gtr:id>51E3860D-5758-4DC7-A545-68AD267FA83F</gtr:id><gtr:firstName>Liam</gtr:firstName><gtr:surname>Heaney</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2CDD30DF-3FDD-4163-BB88-E84A4B6AFF72"><gtr:id>2CDD30DF-3FDD-4163-BB88-E84A4B6AFF72</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>Johnston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001795"><gtr:id>F7F43AFF-28D5-4E39-B516-3FC67CAEB773</gtr:id><gtr:title>The Regulatory Importance of SOCS molecules in Th2 Immune Responses and Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001795</gtr:grantReference><gtr:abstractText>Atopic dermatitis, asthma, hay fever and food allergy can adversely affect the quality of life for many people and while current treatments for allergic disease treat the symptoms there are no cures. White blood cells called a Th2 lymphocyte are thought to be the ultimate cause of allergic disease and the work outlined in this proposal aims to understand some of the key mechanisms that determine how Th2 lymphocytes develop and predispose to allergic disease. We have found that two suppressor proteins called SOCS2 and SOCS3 appear to counteract each other in the development of these allergic Th2 cells. We have obtained genetically engineered mice that lack SOCS2 and will use this model to determine whether these mice develop asthma infections and other allergic disease. We will also address whether they can clear worm infections more efficiently, another key feature of these Th2 lymphocytes. These mice and other key models outlined in the proposal will also allow us to determine whether drugs that target these SOCS in Th2 cells will have the potential to cure allergic diseases</gtr:abstractText><gtr:technicalSummary>Allergies are systemic disorders that manifest as atopic dermatitis (AD), food allergy and allergic rhinitis (AR), all characterised by elevated IgE levels and peripheral eosinophilia. The aetiology of allergy involves complex interactions between local and systemic immune responses, but Th2-cell differentiation and expression of Th2-type cytokines are important in disease development. Significantly higher levels of IL-4 and IL-13 lead to isotype switching to IgE synthesis. Polarisation of different CD4+ T-helper cell subsets is driven by cytokines. The suppressors of cytokine signalling (SOCS) family control cytokine signalling and the contribution of SOCS (1, 2 and 3) to the development of T helper 2 (Th2) allergic disease is the focus of this proposal. We have found that SOCS2-/- CD4+ T cells have markedly enhanced Th2 differentiation and that SOCS2-/- mice have elevated type 2 cytokine production after helminth antigen challenge. Moreover, in in vivo models, of atopic dermatitis SOCS2-/- mice had significantly elevated specific IgE, eosinophilia, type 2 responses and inflammatory pathology relative to WT mice. This preliminary work supports the hypothesis that SOCS2 null CD4+ T cells are prone to develop into Th2 thus these mice are prone to allergy. Are key goals are to 
1) Examine T-helper polarization &amp;amp; signalling in SOCS2-/- T cells
2) Explore if Th2 responses directly linked to SOCS dysregulation in CD4+ T cells? 
3) Measure SOCS expression seen in T-cells from patients with allergy to determine if this is also true in patients.
This work will have important implications in the understanding of molecular mechanisms involved in the predisposition to atopic disease</gtr:technicalSummary><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>435999</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Collaboration Trinity College Dublin</gtr:description><gtr:id>02051E63-BA66-44C2-929F-CE2C9713F54F</gtr:id><gtr:impact>Knosp CA, Carroll HP, Elliott J, Saunders SP, Nel HJ, Amu S, Pratt JC, Spence S, Doran E, Cooke N, Jackson R, Swift J, Fitzgerald DC, Heaney LG, Fallon PG, Kissenpfennig A, Johnston JA. SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses. J Exp Med. 2011 Jul 4;208(7):1523-31.</gtr:impact><gtr:outcomeId>VMmRqhxorzG-1</gtr:outcomeId><gtr:partnerContribution>In vivo models of Inflammation (SOCS2/SOCS3 KO)
Training in establishing models of disease at QUB
Providing Reagents</gtr:partnerContribution><gtr:piContribution>Provide SOCS2 and SOCS3 models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a new SOCS3 conditional knockout (SOCS3fl/fl x CD4-Cre), and a double knockout for SOCS2 &amp;amp; SOCS3 in T cells.</gtr:description><gtr:id>DB699C62-4E08-45B0-8E73-51E1340BA152</gtr:id><gtr:impact>Nothing of yet</gtr:impact><gtr:outcomeId>CpMi7Qg9PQS</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>SOCS2 and SOCS3 models</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A9FCA584-7360-423F-AC1B-075420D36563</gtr:id><gtr:title>STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration.</gtr:title><gtr:parentPublicationTitle>Current molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6738ffe8504874637d8ff442bad8580"><gtr:id>b6738ffe8504874637d8ff442bad8580</gtr:id><gtr:otherNames>Chen M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1566-5240</gtr:issn><gtr:outcomeId>589d899da89cf5.45852999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8EF0387-6111-4A41-B05E-6F76027CAAED</gtr:id><gtr:title>SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d82aa3bbd60bb36cf9f917fb3b39e27f"><gtr:id>d82aa3bbd60bb36cf9f917fb3b39e27f</gtr:id><gtr:otherNames>Knosp CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>i2Y5gAimK1y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36DA9AEC-DD31-44C6-A119-AD1425FEF0E5</gtr:id><gtr:title>Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d82aa3bbd60bb36cf9f917fb3b39e27f"><gtr:id>d82aa3bbd60bb36cf9f917fb3b39e27f</gtr:id><gtr:otherNames>Knosp CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>DduopDxrtt2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE138BEB-8141-442E-AB54-BF468290931A</gtr:id><gtr:title>Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d82aa3bbd60bb36cf9f917fb3b39e27f"><gtr:id>d82aa3bbd60bb36cf9f917fb3b39e27f</gtr:id><gtr:otherNames>Knosp CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14331_21_23455506</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001795</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>